BR100 Increased By (0.44%)
BR30 Increased By (1.39%)
KSE100 Increased By (0.62%)
KSE30 Increased By (0.61%)
BECO 5.49 No Change ▼ 0.00 (0%)
BML 56.00 Decreased By ▼ -0.76 (-1.34%)
BOP 35.41 Increased By ▲ 0.29 (0.83%)
CNERGY 8.20 Increased By ▲ 0.05 (0.61%)
DCL 11.55 Increased By ▲ 0.04 (0.35%)
FCCL 58.15 Increased By ▲ 1.40 (2.47%)
FCSC 5.15 No Change ▼ 0.00 (0%)
FFL 17.90 Increased By ▲ 0.02 (0.11%)
FNEL 1.25 No Change ▼ 0.00 (0%)
HUMNL 11.10 Decreased By ▼ -0.02 (-0.18%)
KEL 8.56 Increased By ▲ 0.14 (1.66%)
KOSM 6.75 Increased By ▲ 0.17 (2.58%)
MLCF 105.65 Increased By ▲ 2.35 (2.27%)
NBP 202.10 Increased By ▲ 1.92 (0.96%)
PACE 11.28 Decreased By ▼ -0.01 (-0.09%)
PAEL 44.42 Increased By ▲ 0.95 (2.19%)
PIAHCLA 28.66 Increased By ▲ 1.17 (4.26%)
PIBTL 18.75 Increased By ▲ 1.05 (5.93%)
PPL 248.10 Increased By ▲ 3.78 (1.55%)
PRL 35.35 Decreased By ▼ -0.08 (-0.23%)
PTC 66.15 Increased By ▲ 0.80 (1.22%)
SEARL 94.95 Increased By ▲ 1.63 (1.75%)
SSGC 32.04 Decreased By ▼ -0.90 (-2.73%)
TELE 8.93 Increased By ▲ 0.02 (0.22%)
THCCL 66.65 Decreased By ▼ -0.07 (-0.1%)
TPLP 10.76 Decreased By ▼ -0.07 (-0.65%)
TREET 25.22 Increased By ▲ 0.10 (0.4%)
TRG 64.21 Decreased By ▼ -0.69 (-1.06%)
WAVES 10.85 Decreased By ▼ -0.08 (-0.73%)
WTL 1.27 Increased By ▲ 0.02 (1.6%)
Topic

AstraZeneca vaccines

AstraZeneca says EU loses legal bid for more vaccine supplies by end-June

AstraZeneca says EU loses legal bid for more vaccine supplies by end-June

Published 18 Jun, 2021 06:10pm
  • The supply cuts delayed the EU's vaccination drive in the first quarter of the year, when the bloc had initially bet on AstraZeneca to deliver the largest volume of its shots.
  • The court said in a statement that AstraZeneca must deliver 15 million doses by July 26, another 20 million by Aug. 23 and another 15 million by Sept. 27, for a total of 50 million doses.
Britain approves J&J COVID-19 vaccine for use

Britain approves J&J COVID-19 vaccine for use

Published 28 May, 2021 05:36pm
  • Britain also cut its order for the single-dose shot, also known as J&J unit Janssen's vaccine, amid issues with the company's supply chain and reports of rare blood clots.
  • J&J's vaccine is already approved in the United States and European Union, where reports of rare blood clots are being reviewed.
Japan health panel approves Moderna, AstraZeneca COVID-19 vaccines

Japan health panel approves Moderna, AstraZeneca COVID-19 vaccines

Published 20 May, 2021 07:37pm
  • The recommendations by a health ministry panel precede official approval by the government on Friday, national broadcaster NHK reported.
  • Supplies of the Moderna doses have already been imported and are planned for use at mass vaccination centres in Tokyo and Osaka from next week.
Mexico president receives AstraZeneca vaccine against COVID-19

Mexico president receives AstraZeneca vaccine against COVID-19

Published 20 Apr, 2021 07:39pm
*The 67-year-old, who had contracted the coronavirus in January, said he wanted to encourage all older adults to also get vaccinated. "We're sure there is no risk, no danger, that there are no serious side effects," he said.
South Korea suspends AstraZeneca shots for people under 60 amid European review

South Korea suspends AstraZeneca shots for people under 60 amid European review

Published 07 Apr, 2021 07:12pm
  • The European Medical Agency (EMA) is due to announce the results of a review on whether some cases of blood clotting in adults may be linked to the AstraZeneca shot.
  • South Korea's food and drug safety ministry said on Wednesday it had granted final approval for Johnson & Johnson's (J&J) vaccine after a panel of experts ruled the single-dose shot was safe and effective.
Ukraine approves Chinese vaccine as COVID-19 cases hit new record high

Ukraine approves Chinese vaccine as COVID-19 cases hit new record high

Published 03 Apr, 2021 06:41pm
  • Ukraine received its first batch of 215,000 Sinovac doses in March to boost its vaccination programme, which has lagged behind many other European countries and it has so far relied on a single batch of AstraZeneca vaccines from India.
  • "The vaccines of the Chinese company Sinovac Biotech can be trusted," it said.
Netherlands halts use of AstraZeneca vaccine for people under 60

Netherlands halts use of AstraZeneca vaccine for people under 60

Updated 02 Apr, 2021 09:06pm
  • The decision was made following new reports from medicine monitoring agency Lareb and discussions with health authorities, a Health Ministry statement said.
  • "Authorities in the UK, European Union, the World Health Organization have concluded that the benefits of using our vaccine to protect people from this deadly virus significantly outweigh the risks across all adult age groups," it said.
Loading...